Cellular lipid metabolism and the role of lipids in progressive renal disease.
about
Mass spectrometry imaging with high resolution in mass and space.Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failureThe Effect of Holy Qur'an Recitation on Depressive Symptoms in Hemodialysis Patients: A Randomized Clinical Trial.Acute kidney injury: a springboard for progression in chronic kidney diseaseSerum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese populationEffects of a novel cystine-based glutathione precursor on oxidative stress in vascular smooth muscle cellsDiabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes modelAssociation of dyslipidemia with renal outcomes in chronic kidney disease.Antibodies reactive to non-HLA antigens in transplant glomerulopathyHigh-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production.Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.A spiked tissue-based approach for quantification of phosphatidylcholines in brain section by MALDI mass spectrometry imaging.High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.APOL1 G1 genotype modifies the association between HDLC and kidney function in African AmericansFoam cells and the pathogenesis of kidney disease.Human apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunctionQuercetin Protects against Cadmium-Induced Renal Uric Acid Transport System Alteration and Lipid Metabolism Disorder in Rats.Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association.A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.Bardoxolone methyl decreases megalin and activates nrf2 in the kidney.Statins for renal patients: a fiddler on the roof?CD36 and Na/K-ATPase-α1 form a proinflammatory signaling loop in kidney.Therapeutic strategies to slow chronic kidney disease progression.Effect of long-term high-fat diet intake on peripheral insulin sensibility, blood pressure, and renal function in female ratsRelationship Between Dyslipidemia and Albuminuria in Hypertensive Adults: A Nationwide Population-Based StudyStatin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China.Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice.Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease.Inhibition of apoptotic signalling in spermine-treated vascular smooth muscle cells by a novel glutathione precursor.Antiretroviral therapy-induced changes in plasma lipids and the risk of kidney dysfunction in HIV-infected menRenal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosisCholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.
P2860
Q28383071-8124A52A-8332-4B03-B903-466646717264Q28566456-4BB64D0D-F16B-4293-A775-705077B84B05Q30390305-6C8A477F-C6E4-4501-93A9-ECB0BC654A1CQ33840576-E358F972-8BB1-4FCE-A3B2-7E01A3B12F9FQ34086005-08ED4739-DCB8-4F8B-9A00-B124EC798797Q34149757-39982D1B-5703-4E83-8564-53470BF5A8E0Q34237738-830447A3-B970-4A36-B5E1-095269687742Q34580123-2384ABC6-7375-4622-9D1C-DE04B00CEA35Q35012455-F9D1B622-172B-4FAB-BE91-68D7A9E8CCE4Q35055477-2CAEC5E0-5D8F-4281-A62E-0016E28B6B6BQ35167826-AA9BE7DA-5423-4972-BB2B-F82129A2765CQ35232279-9F670F2A-7C4C-4158-B8EA-0DF3A1439E59Q35345555-CD43DC63-73F6-4AE6-B1C3-8B07127F1893Q35500577-A0E11F46-83B7-41D7-A68A-EC3707604DE5Q35549222-DE0F31BF-ED6F-46AB-8E51-00503F1AED8EQ35599191-31869C7A-9672-47A5-AD2B-BEFF410A3554Q35642519-128BBCA2-5D9E-4D18-BC28-521D4604521DQ35646631-00CBA6B3-D7CD-4E26-AC92-DC69C69300ABQ35738502-902B5AD2-9B89-44BA-84C2-E0BB7C5DB175Q35992007-0FBE809F-6072-4C17-8943-F9721E5EF81AQ36012033-D93F83E5-E268-4748-9EB8-3C0383270124Q36020284-036F8126-6D86-4F70-A0E2-2C0F64A7401FQ36224992-DBD29C0B-611D-4597-9ABE-F8B83B6C8A3BQ36257138-952E17E9-0E73-4B14-BB2C-17EAB98FA9CBQ36280389-BA3E7EBC-69AF-4399-976B-7E3EADFDA01BQ36361057-8728DCEA-C004-43D8-B609-535CFD6739DEQ36465544-890ABCB2-B9B6-46B6-94EF-9763D14D53B0Q36510669-EE6C083E-D374-4D9B-B937-5BAAFF6131F5Q36581341-4A755CEB-2706-428B-8836-54E344FECE42Q36837970-A1962847-8AFD-4972-AD6E-534A254EC317Q36944127-FC25F0D9-3901-4489-BAE9-D45C2B911615Q37044688-A52D54D1-722A-481E-BBFB-6B07F9F71E9FQ37049760-F299DEB4-CA6B-43A2-AD62-D30235C4C116Q37093643-5B865399-1234-4285-93BC-B83651B9D0F9Q37107593-45CD65E5-BCBC-48EE-9CA5-937B3BF912C9Q37204118-E42E8901-5343-438C-ACBB-CE55372C7782Q37216929-FAB80319-8912-458B-B473-FE08D2F64479Q37246055-0FA8305C-D943-4851-BF6A-82E8682F44E1Q37392958-EF847C2B-9977-4ED3-9D17-91B602B9219BQ37505250-C623BC99-C5D3-4FF1-8BF3-54FDD0D23563
P2860
Cellular lipid metabolism and the role of lipids in progressive renal disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@ast
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@en
type
label
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@ast
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@en
prefLabel
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@ast
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@en
P356
P1476
Cellular lipid metabolism and the role of lipids in progressive renal disease.
@en
P2093
Christine K Abrass
P356
10.1159/000075925
P577
2003-12-30T00:00:00Z